| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
CareMore Health group is a Cerritos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medical Profiles & Engineering is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
In 1988, a group of advocates, providers, and consumers created the Staten Island AIDS Task Force in response to the health crisis of HIV and AIDS in our community. For many years, the Task Force was the only non-profit community-based organization who...
Redwood Area Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Redwood Area Hospital is based in Redwood Falls, MN. You can find more information on Redwood Area Hospital at www.redwoodareahospital.org